Clinical Trials Browser

Phase 1/2 × Interventional × CTL019 chimeric antigen receptor × Clear all

NCT06101381 2024-12-09

CARTHEDRALL

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03896854 2023-11-29

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01626495 2020-03-23

Pedi CART19

Phase 1/2 Completed

73 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell